Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-15 4:00 pm Purchase |
2023-02-06 | 13G | Evolus, Inc. EOLS |
MILLENNIUM MANAGEMENT LLC | 3,328,597 5.900% |
3,328,597 (New Position) |
Filing History |
| 2023-02-14 2:32 pm Purchase |
2022-12-31 | 13G | Evolus, Inc. EOLS |
FIRST MANHATTAN CO | 4,330,738 7.700% |
995,822 (+29.86%) |
Filing History |
| 2023-02-10 09:32 am Purchase |
2022-12-31 | 13G | Evolus, Inc. EOLS |
Flynn James E | 3,319,000 5.900% |
288,701 (+9.53%) |
Filing History |
| 2023-02-06 4:12 pm Sale |
2022-12-31 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 7,296,543 12.970% |
-167,109 (-2.24%) |
Filing History |
| 2022-06-06 4:53 pm Purchase |
2022-05-25 | 13G | Evolus, Inc. EOLS |
Flynn James E | 3,030,299 5.410% |
3,030,299 (New Position) |
Filing History |
| 2022-02-14 6:16 pm Purchase |
2021-12-31 | 13G | Evolus, Inc. EOLS |
FIRST MANHATTAN CO | 3,334,916 6.000% |
3,334,916 (New Position) |
Filing History |
| 2022-02-08 9:55 pm Purchase |
2021-12-31 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 7,463,652 13.430% |
701,000 (+10.37%) |
Filing History |
| 2021-09-27 4:22 pm Unchanged |
2021-09-02 | 13D | Evolus, Inc. EOLS |
Alphaeon 1 LLC | 6,064,871 11.100% |
0 (Unchanged) |
Filing History |
| 2021-09-17 7:50 pm Sale |
2021-09-02 | 13D | Evolus, Inc. EOLS |
Alphaeon 1 LLC | 6,064,871 11.100% |
-2,597,475 (-29.99%) |
Filing History |
| 2021-04-01 1:24 pm Purchase |
2021-03-25 | 13G | Evolus, Inc. EOLS |
Daewoong Pharmaceutical Co. Ltd. | 3,136,869 7.200% |
3,136,869 (New Position) |
Filing History |
| 2021-03-01 5:22 pm Purchase |
2021-02-18 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 6,762,652 16.700% |
6,762,652 (New Position) |
Filing History |
| 2021-02-16 4:15 pm Sale |
2020-12-31 | 13G | Evolus, Inc. EOLS |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-2,635,000 (Position Closed) |
Filing History |